Analyst Downgrades – PLx Pharma (NASDAQ:PLXP) (NASDAQ:PLXP) Stock Gets Downgraded By Janney Montgomery Scott from Buy to Neutral

ME Staff
-
0

Analyst Ratings For PLx Pharma (NASDAQ:PLXP) (NASDAQ:PLXP)

Today, PLx Pharma (NASDAQ:PLXP) (NASDAQ:PLXP) stock was downgraded by Janney Montgomery Scott from Buy to Neutral with a price target of $14.00.

Some recent analyst ratings include

  • 3/26/2018-Janney Montgomery Scott was Downgraded by analysts at Janney Montgomery Scott from a “Buy ” rating to a ” Neutral” rating. They now have a $14.00 price target on the stock.
  • 8/1/2017-Redburn Partners Upgrade from a “Outperform” rating to a “” rating.
  • 10/26/2016-Raymond James Financial was Downgraded by analysts at Raymond James Financial from a “Outperform ” rating to a ” Mkt Perform” rating.
  • 10/25/2016-Feltl & Co. was Downgraded by analysts at Feltl & Co. from a “Buy ” rating to a ” Hold” rating.

Recent Insider Trading Activity For PLx Pharma (NASDAQ:PLXP) (NASDAQ:PLXP)
PLx Pharma (NASDAQ:PLXP) (NASDAQ:PLXP) has insider ownership of 47.70% and institutional ownership of 25.01%.

  • On 6/14/2017 David Emerson Jorden, CFO, bought 32,727 with an average share price of $6.88 per share and the total transaction amounting to $225,161.76.
  • On 6/14/2017 Gary L Mossman, COO, bought 7,273 with an average share price of $6.88 per share and the total transaction amounting to $50,038.24.
  • On 6/14/2017 Michael J Valentino, Insider, bought 29,091 with an average share price of $6.88 per share and the total transaction amounting to $200,146.08.
  • On 5/21/2014 Jack H Dean, Director, bought 3,000 with an average share price of $9.00 per share and the total transaction amounting to $27,000.00.
  • On 3/18/2014 David Garrett, VP, bought 2,083 with an average share price of $12.00 per share and the total transaction amounting to $24,996.00.
  • On 3/18/2014 Thomas L Harrison, Director, bought 2,000 with an average share price of $12.00 per share and the total transaction amounting to $24,000.00.

Recent Trading Activity for PLx Pharma (NASDAQ:PLXP) (NASDAQ:PLXP)
Shares of PLx Pharma (NASDAQ:PLXP) closed the previous trading session at 4.78 down -0.52 9.72% with 5.550000190734863 shares trading hands.